PL3061765T3 - Pochodna protoescygeniny, sposób jej otrzymywania, zastosowanie i użycie w kompozycjach farmaceutycznych zawierających ten związek - Google Patents
Pochodna protoescygeniny, sposób jej otrzymywania, zastosowanie i użycie w kompozycjach farmaceutycznych zawierających ten związekInfo
- Publication number
- PL3061765T3 PL3061765T3 PL15000566T PL15000566T PL3061765T3 PL 3061765 T3 PL3061765 T3 PL 3061765T3 PL 15000566 T PL15000566 T PL 15000566T PL 15000566 T PL15000566 T PL 15000566T PL 3061765 T3 PL3061765 T3 PL 3061765T3
- Authority
- PL
- Poland
- Prior art keywords
- compound
- preparation
- pharmaceutical composition
- protoescigenin
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15000566.8A EP3061765B1 (en) | 2015-02-27 | 2015-02-27 | Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3061765T3 true PL3061765T3 (pl) | 2018-07-31 |
Family
ID=52633036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15000566T PL3061765T3 (pl) | 2015-02-27 | 2015-02-27 | Pochodna protoescygeniny, sposób jej otrzymywania, zastosowanie i użycie w kompozycjach farmaceutycznych zawierających ten związek |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10370404B2 (pl) |
| EP (1) | EP3061765B1 (pl) |
| AU (1) | AU2016225174B2 (pl) |
| CA (1) | CA2976326A1 (pl) |
| DK (1) | DK3061765T3 (pl) |
| ES (1) | ES2666133T3 (pl) |
| PL (1) | PL3061765T3 (pl) |
| WO (1) | WO2016135553A1 (pl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10162058A1 (de) * | 2001-12-17 | 2003-07-24 | Cospharcon Gmbh | Gefäßaktive, juckreiz- und entzündungslindernde Zubereitung zur Minimierung der unangenehmen Begleiterscheinungen hämorrhoidaler Affekte und Ekzeme im Analbereich sowie als unterstützende Maßnahme zur Intertrigo- und Dekubitus-Prophylaxe bei entsprechend disponierten Personen. |
| WO2008028060A2 (en) | 2006-09-01 | 2008-03-06 | Pacific Arrow Limited | Anti-tumor compounds for inhibiting cancer growth |
| US7488753B2 (en) | 2003-10-09 | 2009-02-10 | Pacific Arrow Limited | Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof |
| CN1938326A (zh) | 2003-11-27 | 2007-03-28 | 格里菲斯大学 | 新的止痛化合物,含有它的提取物和制备方法 |
| CA3115431A1 (en) * | 2010-07-16 | 2012-01-19 | Pacific Arrow Limited | New compounds for treating cancer and other diseases |
| AU2012395673A1 (en) * | 2012-11-30 | 2014-08-14 | Hangzhou Zylox Pharma Co., Ltd. | Rapamycin analogs and methods for making same |
| PL402306A1 (pl) | 2012-12-30 | 2014-07-07 | Instytut Farmaceutyczny | Sposób wytwarzania 3,24;16,22-O,O;O,O-diizopropylideno-protoescygeniny oraz jej postacie krystaliczne |
| PL405376A1 (pl) | 2013-09-16 | 2015-03-30 | Instytut Farmaceutyczny | Modyfikowane pochodne protoescygeniny |
-
2015
- 2015-02-27 PL PL15000566T patent/PL3061765T3/pl unknown
- 2015-02-27 ES ES15000566.8T patent/ES2666133T3/es active Active
- 2015-02-27 EP EP15000566.8A patent/EP3061765B1/en active Active
- 2015-02-27 DK DK15000566.8T patent/DK3061765T3/en active
-
2016
- 2016-02-26 AU AU2016225174A patent/AU2016225174B2/en not_active Ceased
- 2016-02-26 US US15/553,301 patent/US10370404B2/en active Active
- 2016-02-26 WO PCT/IB2016/000187 patent/WO2016135553A1/en active Application Filing
- 2016-02-26 CA CA2976326A patent/CA2976326A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10370404B2 (en) | 2019-08-06 |
| EP3061765B1 (en) | 2018-01-31 |
| EP3061765A1 (en) | 2016-08-31 |
| US20180244714A1 (en) | 2018-08-30 |
| AU2016225174A1 (en) | 2017-09-21 |
| AU2016225174B2 (en) | 2020-05-14 |
| WO2016135553A1 (en) | 2016-09-01 |
| CA2976326A1 (en) | 2016-09-01 |
| ES2666133T3 (es) | 2018-05-03 |
| DK3061765T3 (en) | 2018-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243999A1 (zh) | 新型3-吲哚取代的衍生物、藥物組合物及使用方法 | |
| EP3139920A4 (en) | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | |
| IL259246A (en) | Preparations containing pharmaceutical substances and methods of using them | |
| HK1232229A1 (zh) | '- '-硫代核苷的新型化合物及其製備方法、藥物組合物和應用 | |
| HK1231416A1 (zh) | 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物 | |
| ZA202003663B (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
| IL252397A0 (en) | Pharmaceutical preparations, their preparation and uses | |
| EP3285758A4 (en) | Co-crystal composition and its pharmaceutical use | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| IL258977B (en) | Pyperidyl derivatives, their preparation and pharmaceutical compositions containing them | |
| HK1217303A1 (zh) | 種治療白血病的藥物組合物及其製備方法 | |
| EP3284743A4 (en) | Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof | |
| HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
| HUE053974T2 (hu) | Szemészeti gyógyászati készítmény | |
| IL262929B1 (en) | Preparations for treatment, methods of their preparation and their uses | |
| HK1258765A1 (zh) | 治療性化合物、組合物和它們的使用方法 | |
| HK1257129A1 (zh) | 含有吲哚衍生物的藥物組合物、其製備方法和用途 | |
| LT2957280T (lt) | Kieta farmacinė citizino kompozicija ir jos gamybos būdas | |
| GB201718483D0 (en) | Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof | |
| PL3061765T3 (pl) | Pochodna protoescygeniny, sposób jej otrzymywania, zastosowanie i użycie w kompozycjach farmaceutycznych zawierających ten związek | |
| HUP1400084A2 (hu) | Dabigatran és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói |